Interpretation of management of thyroid eye disease: a consensus statement by the American Thyroid Association and the European Thyroid Association

Authors: Wei Yining,  Zhou Huifang
DOI: 10.3760/cma.j.cn115989-20230512-00175
Published 2023-11-10
Cite as Chin J Exp Ophthalmol, 2023, 41(11): 1111-1114.

Abstract                            【Download PDF】 【Read Full Text

Thyroid eye disease (TED) is an autoimmune disease closely related to Graves’ disease and also the most common orbitopathy, which remains a challenge to diagnose and manage.In addition to the updated clinical practice guideline released by European Group on Graves’ Orbitopathy in 2021 and the Chinese guideline released by Chinese Medical Association in 2022, a consensus statement was made by the American Thyroid Association and the European Thyroid Association in 2022.This consensus statement reviewed the latest research progress and clinical experience summarized from the last few decades as an aid to doctors involved in the management of TED.Further elucidation of key points from the consensus statement will be provided in this paper.

Key words:

Thyroid Eye disease; American Thyroid Association; European Thyroid Association; Consensus; Interpretation

Contributor Information

Wei Yining

Department of Ophthalmology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China

Zhou Huifang

Department of Ophthalmology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China

(Read 40 times, 1 visits today)